ASX
Invex Therapeutics Ltd
IXC:ASX•Healthcare
Sensitive ASX Announcement
Second HREC Approval for IIH EVOLVE Phase III Clinical Trial
Published: 30/09/22, 08:51am (AEST)•3 pages